Detalhe da pesquisa
1.
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1.
Front Psychiatry
; 12: 701729, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34504446